BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND KDR, VEGFR2, 3791, ENSG00000128052, P35968, VEGFR, CD309, FLK1 AND Prognosis
61 results:

  • 1. Integration of scRNA and bulk RNA-sequence to construct the 5-gene molecular prognostic model based on the heterogeneity of thyroid carcinoma endothelial cell.
    Ni Z; Cong S; Li H; Liu J; Zhang Q; Wei C; Pan G; He H; Liu W; Mao A
    Acta Biochim Biophys Sin (Shanghai); 2024 Feb; 56(2):255-269. PubMed ID: 38186223
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Development and validation of an individualized angiogenesis and tumor-infiltrating lymphocytes prognostic signature in nasopharyngeal carcinoma.
    Zhang R; Liao X; Zhang B; Huang X; Qin G; Kong X; Xie Y; Mo Y; Dai J; Gan C; Luo Z; Lu J; Jiang W
    Pathol Res Pract; 2024 Jan; 253():154936. PubMed ID: 38006840
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Candidate Angiogenesis-Related Biomarkers in Patients with Laryngeal Carcinoma (AngLaC): A Prospective Cohort Study.
    Pamuk AE; Gedik ME; Sutay Suslu N; Gunaydin G
    Otolaryngol Head Neck Surg; 2023 Jun; 168(6):1433-1442. PubMed ID: 36939422
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genome-wide DNA methylation signature predict clinical benefit of bevacizumab in non-small cell lung cancer.
    Li B; Jiang C; Xu Y; Fan X; Yang L; Zou B; Fan B; Wang L
    BMC Cancer; 2022 Jul; 22(1):828. PubMed ID: 35906610
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Serum differentially expressed angiogenic cytokines in head and neck vascular malformations.
    Zhang L; Shen Y; Wang Z; Li X; Xia W; Su L; Fan X; Wang D
    J Oral Pathol Med; 2022 Nov; 51(10):911-919. PubMed ID: 35854627
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Antitumour effects of apatinib in progressive, metastatic differentiated thyroid cancer (DTC).
    Shi L; You Q; Wang J; Wang H; Li S; Tian R; Yao X; Wu W; Zhang L; Wang F; Lin Y; Li S
    Endocrine; 2022 Oct; 78(1):68-76. PubMed ID: 35767182
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Effectiveness and safety of sorafenib for renal cell, hepatocellular and thyroid carcinoma: pooled analysis in patients with renal impairment.
    Oya M; Kaneko S; Imai T; Tsujino T; Sunaya T; Okayama Y
    Cancer Chemother Pharmacol; 2022 Jun; 89(6):761-772. PubMed ID: 35445315
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. GINS4 might be a novel prognostic immune-related biomarker of not only esophageal squamous cell carcinoma and other cancers.
    Jin D; Yuan L; Li F; Wang S; Mao Y
    BMC Med Genomics; 2022 Apr; 15(1):75. PubMed ID: 35365175
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Treatment of Recurrent or Metastatic Adenoid Cystic Carcinoma.
    de Sousa LG; Neto FL; Lin J; Ferrarotto R
    Curr Oncol Rep; 2022 May; 24(5):621-631. PubMed ID: 35212920
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine-Refractory Differentiated Thyroid cancer: The REALITY Randomized Clinical Trial.
    Lin Y; Qin S; Li Z; Yang H; Fu W; Li S; Chen W; Gao Z; Miao W; Xu H; Zhang Q; Zhao X; Bao J; Li L; Ren Y; Lin C; Jing S; Ma Q; Liang J; Chen G; Zhang H; Zhang Y; Zhou X; Sang Y; Hou Z
    JAMA Oncol; 2022 Feb; 8(2):242-250. PubMed ID: 34913959
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Stimulator of interferon response cGAMP interactor overcomes ERBB2-mediated apatinib resistance in head and neck squamous cell carcinoma.
    Ye G; Zhang J; Zhang C
    Aging (Albany NY); 2021 Aug; 13(16):20793-20807. PubMed ID: 34459788
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Correlation between vascular endothelial growth factor pathway and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu C; Gu L; Liu Z; Li J; Yao M; Fang C
    BMC Cancer; 2021 Jul; 21(1):836. PubMed ID: 34284746
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Anlotinib in Locally Advanced or Metastatic Medullary Thyroid Carcinoma: A Randomized, Double-Blind Phase IIB Trial.
    Li D; Chi Y; Chen X; Ge M; Zhang Y; Guo Z; Wang J; Chen J; Zhang J; Cheng Y; Li Z; Liu H; Qin J; Zhu J; Cheng R; Xu Z; Zheng X; Tang P; Gao M
    Clin Cancer Res; 2021 Jul; 27(13):3567-3575. PubMed ID: 33832949
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Effects of 6,8-Diprenylgenistein on VEGF-A-Induced Lymphangiogenesis and Lymph Node Metastasis in an Oral cancer Sentinel Lymph Node Animal Model.
    Bae MG; Hwang-Bo J; Lee DY; Lee YH; Chung IS
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466636
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Efficacy of axitinib in metastatic head and neck cancer with novel radiographic response criteria.
    Swiecicki PL; Bellile EL; Brummel CV; Brenner JC; Worden FP
    Cancer; 2021 Jan; 127(2):219-228. PubMed ID: 33079405
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Pharmacological effects of vinorelbine in combination with lenvatinib in anaplastic thyroid cancer.
    Di Desidero T; Orlandi P; Gentile D; Banchi M; Alì G; Kusmic C; Armanetti P; Cayme GJ; Menichetti L; Fontanini G; Francia G; Bocci G
    Pharmacol Res; 2020 Aug; 158():104920. PubMed ID: 32461187
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Effect of mesoporous silica nanoparticles co‑loading with 17‑AAG and Torin2 on anaplastic thyroid carcinoma by targeting vegfr2.
    Wang C; Zhang R; Tan J; Meng Z; Zhang Y; Li N; Wang H; Chang J; Wang R
    Oncol Rep; 2020 May; 43(5):1491-1502. PubMed ID: 32323855
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. PBX3 Promotes Tumor Growth and Angiogenesis via Activation of AT1R/vegfr2 Pathway in Papillary Thyroid Carcinoma.
    Chen Q; Yu WY; Zhang HH; Zhang SZ; Fang J; Wu F; Ying HZ; Yu CH
    Biomed Res Int; 2020; 2020():8954513. PubMed ID: 32047817
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Chemo-resistant Gastric cancer Associated Gene Expression Signature: Bioinformatics Analysis Based on Gene Expression Omnibus.
    Liu JB; Jian T; Yue C; Chen D; Chen W; Bao TT; Liu HX; Cao Y; Li WB; Yang Z; Hoffman RM; Yu C
    Anticancer Res; 2019 Apr; 39(4):1689-1698. PubMed ID: 30952707
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Cystic Hygroma: A Preliminary Genetic Study and a Short Review from the Literature.
    Noia G; Maltese PE; Zampino G; D'Errico M; Cammalleri V; Convertini P; Marceddu G; Mueller M; Guerri G; Bertelli M
    Lymphat Res Biol; 2019 Feb; 17(1):30-39. PubMed ID: 30475086
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.